Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,941.00
Bid: 1,942.00
Ask: 1,944.00
Change: -38.00 (-1.92%)
Spread: 2.00 (0.103%)
Open: 1,981.00
High: 1,992.00
Low: 1,941.00
Prev. Close: 1,979.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

Tue, 24th May 2022 08:24

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

The London-based bank said at the time that securities offered and sold under its US shelf registration statement for an approximate one-year period had exceeded a registered amount. This, the bank explained, gave the purchasers of the affected securities a right of rescission, requiring Barclays Bank to repurchase the affected securities at their original purchase price.

Late on Monday, Barclays provided further explanation.

"The provision for over-issuance of US securities is particularly sensitive to equity market movements, however, this would be expected to be substantially offset by hedging arrangements, including specific hedging and overall portfolio positioning," it said.

Barclays said it had found "one material weakness" in its internal controls.

"The material weakness that has been identified relates to a weakness in controls over the identification of external regulatory limits related to securities issuance and monitoring against these limits. As a result of this weakness, BBPLC issued securities in excess of the amount registered under the US shelf," it said on Monday.

Barclays shares were up 1.8% early Tuesday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.9% at 7,443.82

----------

Hang Seng: down 2.0% at 20,054.66

Nikkei 225: closed down 0.9% at 26,748.14

S&P/ASX 200: closed down 0.3% at 7,128.80

----------

DJIA: closed up 618.34 points, or 2.0%, at 31,880.24

S&P 500: closed up 72.39 points, or 1.9%, at 3,973.75

Nasdaq Composite: closed up 180.66 points, or 1.6%, at 11,535.27

----------

EUR: down at USD1.0673 (USD1.0690)

GBP: flat at USD1.2578 (USD1.2575)

USD: down at JPY127.56 (JPY127.78)

Gold: down at USD1,852.53 per ounce (USD1,854.61)

Oil (Brent): down at USD111.97 a barrel (USD112.23)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Tuesday's key economic events still to come

0930 CEST Germany flash purchasing managers' index

1000 CEST EU flash PMI

0930 BST UK S&P Global-CIPS flash PMI

1100 BST UK CBI distributive trades survey of business conditions

0855 EDT US Johnson Redbook retail sales index

0945 EDT US flash manufacturing PMI

0945 EDT US flash services PMI

1000 EDT US new residential sales

1000 EDT US Richmond Fed business activity survey

1630 EDT US API weekly statistical bulletin

----------

UK government borrowing remains stubbornly high, still above pre-Covid times, according to numbers from the Office for National Statistics. Public sector net borrowing, excluding banks, amounted to GBP18.6 billion in April. It was the fourth-highest April figure since monthly records began in 1993.The figure was down from GBP24.2 billion a year earlier but up from GBP10.7 billion in April 2019. April's figure climbed from GBP14.7 billion in March 2022. The figure for the financial year ended March, meanwhile, was downwardly revised to GBP144.6 billion from GBP151.8 billion. It remains the third-highest borrowing number since financial year records began in March 1947, however.

----------

Hundreds of people gathered in central London on Tuesday morning in an attempt to be among the first passengers on the new Elizabeth Tube line, PA reports. Transport enthusiasts hailed the "momentous occasion", having travelled from across the country for the ceremony and queued from the early hours of the morning. Around 300 people queued outside Paddington Station ahead of the service's opening at 6.30am, and the crowd cheered and rushed forwards when the doors opened at around 6.20am. The first train departed on time at 6.33am carrying hundreds of excited passengers.

----------

BROKER RATING CHANGES

----------

Peel Hunt cuts Royal Mail to 'sell' (buy) - price target 307 (550) pence

----------

Citigroup cuts SSE to 'neutral' (buy) - price target 1937 (1829) pence

----------

SocGen raises Kingfisher to 'hold' (sell) - price target 271 (260) pence

----------

COMPANIES - FTSE 100

----------

Siggi Olafsson resigns as chief executive officer of Hikma Pharmaceuticals "to pursue other opportunities", leaving on June 24. Executive Chair Said Darwazah will take over all CEO responsibilities while the board looks for a new CEO. Darwazah is the former CEO of Hikma. Olafsson has been in post for four years.

----------

KPMG has been hit with a GBP3.37 million fine by the audit watchdog over failings working on accounts for engineering firm Rolls-Royce Holdings. The big four auditor was told it could face a fine of up GBP4.5 million but saw this reduced after admissions related to the case. The Financial Reporting Council first launched an investigation into KPMG's conduct in 2017 over bribery allegations following a probe by the Serious Fraud Office. KPMG had been Rolls-Royce auditor since 1990 but was sacked by the FTSE firm after agreeing a settlement with the SFO and US Department for Justice amid bribery claims. It resulted in the auditor paying out GBP670 million in fines.

----------

COMPANIES - FTSE 250

----------

Homeserve reported revenue of GBP1.43 billion for the financial year ended March 31, up 10% from GBP1.30 billion a year earlier. Pretax profit surged to GBP175.1 million from GBP47.2 million. "Homeserve has emerged from the Covid-19 pandemic with all three of our business divisions performing strongly. Our membership-based business model continues to be resilient, predictable and highly cash generative, and we are well positioned for continued growth," Chief Executive Richard Harpin said. Homeserve's annual results come in the wake of the company agreeing to be taken over in a GBP4 billion deal. Hestia Bidco, a subsidiary of Brookfield Infrastructure Partners, offered 1,200p per share in cash for each Homeserve share last week Thursday. The company is not declaring a final dividend in light of the deal. It had paid a 19.8 pence final payout a year prior. It means its total dividend for the year is 6.8p, down from 26p.

----------

SSP Group said revenue in the six months that ended March 31 was up more than three-fold to GBP803.2 million from GBP256.7 million a year earlier. Compared to financial 2019 levels, however, revenue was 36% lower. SSP's pretax loss was narrowed substantially to GBP2.3 million from GBP299.7 million. The better top and bottom line figures were "driven by a recovery in passenger numbers, despite the impact of the spread of the Omicron variant in many of our markets in December and January", SSP said. "The recovery has been led by leisure travellers, with business related travel recovering more slowly as expected. Encouragingly we have also seen increased spend per passenger in some markets reflecting the higher proportion of leisure travellers." SSP is unable to pay dividends due to arrangements with its lenders but said it will "consider the best way to restart the return of capital to shareholders".

----------

COMPANIES - SMALL CAP

----------

Restaurant Group left annual expectations unchanged as like-for-like sales across its units were largely higher versus pre-virus figures. In the Wagamama unit, like-for-like sales in 2022 to date are up 15% from 2019, while in its Pubs and Leisure segments, they are 10% and 6% higher, respectively. In Concessions, they are down 20%, however. "Management's current expectations for FY22 remain unchanged, with continued robust trading in our Wagamama and Pubs businesses and the stronger recovery in Concession sales offsetting the increased food and drink inflationary impact in FY22," Restaurant Group said, looking ahead.

----------

On the Beach's revenue in the half year ended March 31 jumped to GBP52.9 million from GBP4.4 million a year earlier. The travel agency's revenue was boosted by the easing of virus curbs. Half-year revenue was below the pre-pandemic figure of GBP63.5 million. Pretax loss in the first half of the current financial year was trimmed to GBP7.0 million from GBP12.1 million a year prior. "Sales have remained resilient into H2 and are 33% ahead of FY19 in the 8 weeks to 22 May 2022," the company said.

----------

COMPANIES - GLOBAL

----------

Toyota Motor is cutting production by tens of thousands of vehicles globally because of semiconductor shortages. The global production plan for June is about 850,000 units, of which 250,000 units are in Japan and 600,000 units overseas. The average global production plan from June through August is about 850,000 units, and 9.7 million units for the full period of fiscal year 2023. The shortage of semiconductors, spread of Covid-19 and other factors are making it difficult to look ahead, the company said in a statement. In addition, the Japanese car maker announced additional domestic factory line suspension due to supply shortages caused by Covid-19 lockdown in Shanghai.

----------

Samsung Electronics unveiled a massive USD356 billion investment blueprint for the next five years aimed at making it a frontrunner in a wide range of sectors from semiconductors to biologics. The new figure is an increase of more than a third over its earlier plan announced last year. Samsung is South Korea's largest conglomerate and its overall turnover is equivalent to a fifth of the national gross domestic product. Samsung Electronics, its flagship subsidiary, is the world's biggest smartphone maker. The investment plan would bring "long-term growth in strategic businesses and help strengthen the global industrial ecosystem of crucial technology", Samsung said in a statement.

----------

Tuesday's shareholder meetings

4imprint Group PLC - AGM

Afentra PLC - AGM

Artisanal Spirits Co PLC - AGM

Bidstack Group PLC - AGM

Epwin Group PLC - AGM

FDM Group Holdings PLC - AGM

Forterra PLC - AGM

Harworth Group PLC - AGM

Henderson High Income Trust PLC - AGM

Hill & Smith Holdings PLC - AGM

Hilton Food Group PLC - AGM

Horizonte Minerals PLC - AGM

Judges Scientific PLC - AGM

Pebble Group PLC - AGM

Quarto Group Inc - AGM

Restaurant Group PLC - AGM

Riverstone Energy Ltd - AGM

Shell PLC - AGM

Thungela Resources Ltd - AGM

Vector Capital PLC - AGM

WPP PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.